Overview / Abstract: |
Target Audience This activity is designed to meet the educational needs of Neurologists and MS nurse specialists, as well as other clinicians treating and managing patients with MS. Program Overview Recent advances in the field of immunology and the increasing recognition of inflammatory pathways are re-shaping the conceptualization of multiple sclerosis (MS), with potential implications of new agents within the current landscape of treatment options. This CME/CNE activity features clinicians and researchers who will provide expert insights and updated evidence for immune-directed strategies in MS. Their presentations will describe the rationale for immune system reset along with supporting clinical evidence, and identify risks and benefits of current and emerging DMTs, including understanding of complications (i.e., infections, malignancy potential), as well as strategies for optimizing sequencing of therapies in individualized MS patient care. Learning Objectives After participating in this accredited satellite symposium, the learner should be able to: Describe critical advances and emerging immune-directed therapies that will change the therapeutic approach to MS. |
Expiration |
Apr 20, 2021 |
Discipline(s) |
Nursing CNE, Physician CME |
Format |
Online |
Credits / Hours |
1.0 AMA PRA Category 1 Credit(s)™ |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Faculty Mark Freedman, MSc, MD, FANA, FAAN, FRCPC, Co-Chair Patricia K. Coyle, MD, FAAN, FANA, Co-Chair |
Sponsors / Supporters / Grant Providers |
EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany. |
Keywords / Search Terms |
Relias LLC Relias LLC., FREE CME, Immune-directed Therapies Free CE CME |